Abbott's Advanced Dual System to help manage diabetes

Managing diabetes can be challenging. Every one of your diet and lifestyle choices matter to help you stay in control. Be in control today with Abbott’s Advanced Dual System, incorporate Glucerna^®, a diabetes-specific formula into your daily meal plan and get feedback on how your diet and exercise choices would affect your glucose with FreeStyle Libre. Start right today to manage and monitor diabetes with ease and confidence!

Start your day with a convenient and nutritious diet choice - Glucerna^®

Glucerna^® is a low GI product that has been extensively studied and has a unique formulation to help with the body’s natural process to help manage blood sugar¹. Glucerna’s new, advanced blend of ingredients is designed to help support dietary management of diabetes.

Read more about Glucerna^® or request for a free sample.

And monitor your glucose in a painless 1-second scan³ with Freestyle Libre.

Click here to learn more about FreeStyle Libre.

Diabetes is complex enough. Managing diabetes shouldn’t be.

Choose Abbott’s Advance Dual System and experience managing diabetes with ease and confidence.

References

Images and readings are for illustration purpose only.
*These intervention alongside medication and physical activities for optimal diabetes control.
1. Postprandial glycemic response.
2. Compared to previous version of Glucerna.
3. Most people did not feel any discomfort under the skin while wearing the FreeStyle Libre sensor. In a study conducted by Abbott Diabetes Care, 93.4% of patients surveyed (n=30) strongly agree or agree that while wearing the sensor, they did not feel any discomfort under their skin. [29 persons have finished the study; 1 person terminated the study after 3 days due to skin irritations in the area where the sensor touched the skin].
4. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycemia or impending hypoglycemia is reported by the system or when symptoms do not match the system readings.

MAL.2021.11725.GLU.1 (v1.1) 01/23